Startseite>>Signaling Pathways>> Others>> Inhibitory Antibodies>>Labetuzumab

Labetuzumab

Katalog-Nr.GC69349

Labetuzumab is a humanized monoclonal antibody against carcinoembryonic antigen (CEA), which can inhibit tumor growth and make human medullary thyroid cancer xenografts sensitive to Dacarbazine chemotherapy.

Products are for research use only. Not for human use. We do not sell to patients.

Labetuzumab Chemische Struktur

Cas No.: 219649-07-7

Größe Preis Lagerbestand Menge
5mg
756,00 $
Auf Lager
10mg
1.215,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Bewertungen

Review for Labetuzumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Labetuzumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.